Latest Breaking News On - Shenzhen hepalink pharmaceutical group company profile - Page 1 : comparemela.com

The Goldman Sachs Group lowered shares of Shenzhen Hepalink Pharmaceutical Group (OTCMKTS:SHEZF – Free Report) from a neutral rating to a sell rating in a research report sent to investors on Thursday morning, FlyOnTheWall reports. Shenzhen Hepalink Pharmaceutical Group Stock Performance SHEZF opened at $0.72 on Thursday. Shenzhen Hepalink Pharmaceutical Group has a twelve month […]

United statesHong kongManufacturing organizationShenzhen hepalink pharmaceutical group co ltdGoldman sachs groupShenzhen hepalink pharmaceutical group company profileContract developmentShenzhen hepalink pharmaceutical groupShenzhen hepalink pharmaceutical group stock performanceFree reportGet free reportMainland chinaActive pharmaceutical ingredientsShenzhen hepalink pharmaceutical group dailyOtcmkts shezfThe goldman sachs group inc